![]() |
|
|
Vol. 288, Issue 1, 157-163, January 1999
Departments of Anesthesiology and Biomedical Engineering,
Northwestern University Medical School, Chicago, Illinois
Fentanyl is a basic amine shown to have extensive first-pass pulmonary
uptake. To evaluate the role of the pulmonary endothelium in this
uptake process, the simultaneous pharmacokinetics of
[3H]fentanyl and two marker drugs, blue dextran, and
[14C]antipyrine, were evaluated in a flow-through system
of pulmonary endothelial cells. Fentanyl equilibrium kinetics were
determined in a static culture system. The flow-through system
consisted of monolayers of bovine pulmonary artery endothelial cells
cultured on solid microcarrier beads placed in a chromatography column and perfused at 1.0 ml/min (37°C). Fentanyl and the markers were injected into the perfusate at the top of the column and samples were
collected from the eluate at 9-s intervals for 10 min. The pharmacokinetic analyses were based on determinations of mean transit
time and flow. Fentanyl was partitioned into the pulmonary endothelial
cells 60 times more than the tissue water space marker antipyrine. In
the static system, monolayers of bovine pulmonary artery endothelial
cells were cultured in 3.8-cm2 wells to which were added 0 to 946 µmol (0-500 µg/ml) of unlabeled fentanyl citrate and 0.14 µmol of [3H]fentanyl. After a 10-min incubation,
solubilized cells were assayed for [3H]fentanyl.
Pulmonary endothelial cells contained a higher relative fentanyl
concentration at lower fentanyl supernatant concentrations than would
be expected if uptake occurred by diffusion alone. These observations
can be explained with a model of fentanyl uptake that includes both
passive diffusion and saturable active uptake. This suggests that the
extensive first-pass pulmonary uptake of fentanyl observed in vivo is
due largely to vascular endothelial drug uptake by both a passive and a
saturable active uptake process.
This article has been cited by other articles:
![]() |
I. A. Elkiweri, Y. L. Zhang, U. Christians, K.-Y. Ng, M. C. Tissot van Patot, and T. K. Henthorn Competitive Substrates for P-Glycoprotein and Organic Anion Protein Transporters Differentially Reduce Blood Organ Transport of Fentanyl and Loperamide: Pharmacokinetics and Pharmacodynamics in Sprague-Dawley Rats Anesth. Analg., January 1, 2009; 108(1): 149 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Ferguson and G. B. Drummond Acute effects of fentanyl on breathing pattern in anaesthetized subjects Br. J. Anaesth., March 1, 2006; 96(3): 384 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dahan, A. Yassen, H. Bijl, R. Romberg, E. Sarton, L. Teppema, E. Olofsen, and M. Danhof Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats Br. J. Anaesth., June 1, 2005; 94(6): 825 - 834. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Boer Drug handling by the lungs Br. J. Anaesth., July 1, 2003; 91(1): 50 - 60. [Full Text] [PDF] |
||||
![]() |
T. K. Henthorn, Y. Liu, M. Mahapatro, and K.-y. Ng Active Transport of Fentanyl by the Blood-Brain Barrier J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1084 - 1089. [Abstract] [Full Text] |
||||